share_log

石藥集團:自願公告 - 新型冠狀病毒mRNA疫苗(SYS6006)完成一項序貫加強免疫的臨床研究

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - COMPLETION OF A CLINICAL STUDY OF HETEROLOGOUS BOOSTER IMMUNIZATION OF SARS-CoV-2 mRNA VACCINE (SYS6006)

Aug 23, 2022 17:25

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.